Log In
BCIQ
Print this Print this
 

denileukin diftitox (E7777)

  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionRecombinant cytotoxic fusion protein that combines the interleukin-2 (IL-2) receptor binding domain with diphtheria toxin fragments A and B
Molecular Target Interleukin-2 (IL-2) receptor
Mechanism of ActionCytotoxic fusion protein
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/31/2016

Undisclosed

0

Undisclosed

Get a free BioCentury trial today